| Literature DB >> 35706641 |
Soumya Sarkar1, Puneet Khanna1, Deepak Gunjan2.
Abstract
Peroral endoscopic myotomy (POEM) is a promising natural orifice transluminal endoscopic procedure for the treatment of esophageal motility disorders, with similar effectiveness as of Heller myotomy. It is performed under general anesthesia in endoscopy suite. Creation of submucosal tunnel in the esophageal wall is a key component. The continuous insufflation of CO2 inadvertently tracks into surrounding tissues and leads to capno mediastinum, capno thorax, capno peritoneum, and subcutaneous emphysema. Thus, the challenges, for an anesthesiologist are not only providing remote location anesthesia, increased risk of aspiration during induction, but also early detection of these complications and specific emergency management. Though a therapeutic innovation, POEM remains an interdisciplinary challenge with no specific anesthesia care algorithms and evidence-based recommendations. The purpose of this review is to outline the anesthesia and periprocedural practices based on existing evidence. Copyright:Entities:
Keywords: Anesthesia; POEM; complications; management
Year: 2021 PMID: 35706641 PMCID: PMC9191809 DOI: 10.4103/joacp.JOACP_179_20
Source DB: PubMed Journal: J Anaesthesiol Clin Pharmacol ISSN: 0970-9185
Figure 1Endoscopic image shoeing dilated esophageal lumen, which is filled with food residue
Figure 2Mucosal bleb (blue color) after injection of normal saline mixed with methylene blue dye in the submucosal space
Figure 3Submucosal tunnel after clearing of submucosal space. At 12 O’clock is the mucosa and at 6 O’clock is the muscle layer of the esophageal wall
Figure 4Submucosal tunnel after the myotomy. At 12 O’clock is the longitudinal muscle layer visible after the selective circular muscle myotomy
Figure 5Closure of the mucosal incision site by the multiple hemoclips
Indications and Contraindications for POEM[14]
| Indications | Contra indications |
|---|---|
| Classic indication: | Absolute contraindications |
ASGE guidelines (2016) for antithrombotic agents in patients undergoing GI endoscopy[15]
| Drugs | Low cardiovascular Risk | High Cardio vascular Risk |
|---|---|---|
| Anti-coagulants (AC) | 1. Discontinue AC | 1. Discontinue AC |
| Antiplatelet agents (APA) | 1. Continue standard doses of aspirin/NSAIDs* | 1. Continue standard doses of aspirin/NSAIDs |
1. Defer elective endoscopic procedures, possibly up to 12 months, if clinically acceptable from the time of PCI to DES placement. 2. Avoid cessation of clopidogrel (even when aspirin is continued) within the first 30 days after PCI and either DES or BMS placement when possible. 3. Avoid cessation of all antiplatelet therapies after PCI with stent placement. 4. Perform endoscopic procedures, particularly those associated with bleeding risk, 5-7 days after thienopyridine drug cessation. 5. Aspirin should be continued. 6. Resumption of thienopyridine and ASA drug therapy after the procedure once hemostasis is achieved. A loading dose of the former should be considered among patients at risk for thrombosis
Induction agent considerations[22]
| Induction agent | Advantages | Disadvantages | Suggested use |
|---|---|---|---|
| Sodium thiopental 3-7 mg kg−1 | Clear endpoint; rapid one arm brain circulation time | Postoperative nausea and vomiting | Traditional choice |
| Propofol 2-4 mg kg−1 | Greater suppression of laryngeal reflexes Familiarity | CVS depression | When intubating conditions are a concern |
| Etomidate 0.3 mg kg−1 | CVS stability | Adrenal suppression | CVS instability |
| Ketamine 1-2 mg kg−1 | Bronchodilation CVS stimulant; maintains cerebral perfusion pressure in hypotensive situations | Increases ICP | Asthma, Shocked states |